Alphamab Oncology's market cap is currently HK$11.95B. The company's EPS TTM is HK$0.0218706156; its P/E ratio is 46.78; Alphamab Oncology is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
